Concepedia

Caroline Sibilla

CS

Statistics

Publications

6

Citations

275

H-Index

6

Active since

2016

Affiliations

National Institute of Neurological Disorders and Stroke(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

BC Cancer Agency

AstraZeneca (United States)

Peter MacCallum Cancer Centre

Caroline Sibilla is an author at National Institute of Neurological Disorders and Stroke specializing in medicine, signal transduction, and oncology.

ORCID

Top concepts

Publications per year

2016–2022

6

Publications

6

<i>Reep1</i>null mice reveal a converging role for hereditary spastic paraplegia proteins in lipid droplet regulation

Benoît Renvoisé, Brianna Malone, Mélanie Falgairolle et al. · Human Molecular Genetics · 2016 · 84 citations · Full text

, , +16

Detection of <i>BRCA1</i> , <i>BRCA2</i> , and <i>ATM</i> Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound

Kim N., Alan Barnicle, Caroline Sibilla et al. · Clinical Cancer Research · 2022 · 62 citations · Full text

Clueless/CLUH regulates mitochondrial fission by promoting recruitment of Drp1 to mitochondria

Huan Yang, Caroline Sibilla, Raymond Liu et al. · Nature Communications · 2022 · 51 citations · Full text

Prion‐like protein aggregates exploit the RHO GTPase to cofilin‐1 signaling pathway to enter cells

Zhen Zhong, Laura Grasso, Caroline Sibilla et al. · The EMBO Journal · 2018 · 40 citations · Full text

, , +9

Concordance of <i>BRCA1</i>, <i>BRCA2</i> (BRCA), and <i>ATM</i> mutations identified in matched tumor tissue and circulating tumor DNA (ctDNA) in men with metastatic castration-resistant prostate cancer (mCRPC) screened in the PROfound study.

Kim N., Alan Barnicle, Caroline Sibilla et al. · Journal of Clinical Oncology · 2021 · 27 citations

, , +20

1–5 of 6